$12.39
At close: May 13, 5:00 PM EST
$12.63
0.241.94%
Pre-Market: 3:00 AM EST
Amneal Pharmaceuticals Inc Stock Guidance
AMRXNASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, after the market close
Amneal Pharmaceuticals (AMRX) last issued guidance on May 7, 2026 for fiscal year 2026. The company guided earnings per share in the range of $0.95 - $1.05, compared to a consensus EPS estimate of $0.98. Amneal Pharmaceuticals also guided revenue in the range of $3.05B - $3.15B for the period.
Compared to prior guidance, Amneal Pharmaceuticals maintained its EPS outlook from a previous range of $0.95 - $1.05. On the revenue side, the company maintained its revenue forecast from a prior range of $3.05B - $3.15B.
Amneal Pharmaceuticals has issued 26 guidance updates between August 5, 2022 and May 7, 2026. During this period, the company raised its outlook 10 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 7, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$0.95 - $1.05
Revenue Guidance Range
$3.05B - $3.15B
Amneal Pharmaceuticals Guidance History
Review all historical guidance issued by Amneal Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Amneal Pharmaceuticals (AMRX)?
The most recent guidance for Amneal Pharmaceuticals (AMRX) was reported on May 7, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $0.95 to $1.05, compared to the estimated EPS of $0.98. Additionally, Amneal Pharmaceuticals forecasted revenue between $3.05B and $3.15B for the period.
What EPS range did Amneal Pharmaceuticals (AMRX) guide for?
Amneal Pharmaceuticals (AMRX) guided EPS in the range of $0.95 to $1.05 for the fiscal year 2026. The consensus analyst EPS estimate is $0.98.
What revenue range did Amneal Pharmaceuticals (AMRX) guide for?
Amneal Pharmaceuticals (AMRX) guided revenue in the range of $3.05B to $3.15B for the fiscal year 2026.
Did Amneal Pharmaceuticals (AMRX) raise or lower guidance?
Amneal Pharmaceuticals (AMRX) maintained its EPS guidance from a prior range of $0.95 - $1.05 to $0.95 - $1.05 for the fiscal year 2026.
When did Amneal Pharmaceuticals (AMRX) last issue guidance?
Amneal Pharmaceuticals (AMRX) last issued guidance on May 7, 2026 for the fiscal year 2026.
